drugset / Trial / NCT02439632

A Multi-center, Randomized, Double-blind, Double-dummy Clinical Study to Evaluate the Safety and Efficacy of Prulifloxacin Film-coated Tablet for the Treatment of Acute Uncomplicated Lower Urinary Tract Infection With Levofloxacin Hydrochloride Tablet as Active Control

NCT02439632

Phase 3 Completed 216 enrolled Lee's Pharmaceutical Limited
RandomizedParallel-groupDouble-blindTreatment

Summary

prulifloxacin is not inferior to levofloxacin hydrochloride in treating acute uncomplicated lower urinary tract infection in chinese

Timeline

Start
2014-02
Primary completion
2015-03
Completion
2015-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Levofloxacin Small molecule 250 mg Oral
Subject Prulifloxacin Small molecule 600 mg Oral